Table 2 Treatment characteristics of women with breast cancer diagnosed during 2016–2020 at the National Cancer Institute, Sri Lanka
Type of treatment | Early (%) | Advanced (%) | Total n (%) |
|---|---|---|---|
Surgery – Breast | |||
Mastectomy only | 2101 (61) | 1271 (73) | 3372 (65) |
Mastectomy + reconstruction | 32 (1) | 9 (1) | 41 (1) |
Wide local excision | 1107 (32) | 154 (9) | 1261 (24) |
No surgery | 187 (6) | 315 (18) | 502 (10) |
Missing | 1 (< 1) | 4 (< 1) | 5 (< 1) |
Surgery – Axillary | |||
Sentinel LN biopsy | 1034 (30) | 78 (4) | 1112 (22) |
Axillary clearance | 2174 (63) | 1344 (77) | 3518 (68) |
No axillary surgery | 219 (6) | 326 (19) | 545 (10) |
Missing | 1 (< 0.1) | 5 (< 1) | 6 (< 1) |
Neoadjuvant chemotherapy | |||
Yes | 126 (4) | 478 (27) | 604 (12) |
No | 3302 (96) | 1275 (73) | 4577 (88) |
Adjuvant chemotherapy | n = 4270 | ||
Yes | 1888 (67) | 994 (68) | 2882 (68) |
No | 915 (33) | 473 (32) | 1388 (32) |
Adjuvant radiotherapy | n = 4270 | ||
Yes | 1578 (56) | 996 (68) | 2574 (50) |
No | 1221 (43) | 475 (32) | 1696 (33) |
Adjuvant endocrine therapy | n = 4266 | ||
Yes | 1833 (65) | 847 (58) | 2680 (52) |
No | 964 (35) | 622 (42) | 1586 (31) |